328 related articles for article (PubMed ID: 34407291)
21. Melanoma biology and treatment: a review of novel regulated cell death-based approaches.
Hsieh MY; Hsu SK; Liu TY; Wu CY; Chiu CC
Cancer Cell Int; 2024 Feb; 24(1):63. PubMed ID: 38336727
[TBL] [Abstract][Full Text] [Related]
22. Many ways to resistance: How melanoma cells evade targeted therapies.
Kozar I; Margue C; Rothengatter S; Haan C; Kreis S
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):313-322. PubMed ID: 30776401
[TBL] [Abstract][Full Text] [Related]
23. Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms.
Ma TL; Zhou Y; Wang C; Wang L; Chen JX; Yang HH; Zhang CY; Zhou Y; Guan CX
Oxid Med Cell Longev; 2021; 2021():1098970. PubMed ID: 34630843
[TBL] [Abstract][Full Text] [Related]
24. Frontline BRAF Testing-Guided Treatment for Advanced Melanoma in the Era of Immunotherapies: A Cost-Utility Analysis Based on Long-term Survival Data.
Wu B; Shi L
JAMA Dermatol; 2020 Nov; 156(11):1177-1184. PubMed ID: 32697281
[TBL] [Abstract][Full Text] [Related]
25. Nivolumab: A Review in Advanced Melanoma.
Scott LJ
Drugs; 2015 Aug; 75(12):1413-24. PubMed ID: 26220912
[TBL] [Abstract][Full Text] [Related]
26. Recent progress on targeting ferroptosis for cancer therapy.
Xu G; Wang H; Li X; Huang R; Luo L
Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
[TBL] [Abstract][Full Text] [Related]
27. Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors.
Olbryt M; Rajczykowski M; Widłak W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517213
[TBL] [Abstract][Full Text] [Related]
28. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
[TBL] [Abstract][Full Text] [Related]
29. Ferroptosis: A New Promising Target for Lung Cancer Therapy.
Xiong R; He R; Liu B; Jiang W; Wang B; Li N; Geng Q
Oxid Med Cell Longev; 2021; 2021():8457521. PubMed ID: 34616505
[TBL] [Abstract][Full Text] [Related]
30. Overcoming melanoma drug resistance through metabolic targeting?
Smalley KS
Pigment Cell Melanoma Res; 2013 Nov; 26(6):793-5. PubMed ID: 24152044
[No Abstract] [Full Text] [Related]
31. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.
Zhang C; Liu N
Front Immunol; 2022; 13():920059. PubMed ID: 35958626
[TBL] [Abstract][Full Text] [Related]
32. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
33. uPAR
Porcelli L; Guida M; De Summa S; Di Fonte R; De Risi I; Garofoli M; Caputo M; Negri A; Strippoli S; Serratì S; Azzariti A
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33972390
[TBL] [Abstract][Full Text] [Related]
34. Lymph protects metastasizing melanoma cells from ferroptosis.
Ubellacker JM; Tasdogan A; Ramesh V; Shen B; Mitchell EC; Martin-Sandoval MS; Gu Z; McCormick ML; Durham AB; Spitz DR; Zhao Z; Mathews TP; Morrison SJ
Nature; 2020 Sep; 585(7823):113-118. PubMed ID: 32814895
[TBL] [Abstract][Full Text] [Related]
35. Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
Jang SR; Nikita N; Banks J; Keith SW; Johnson JM; Wilson M; Lu-Yao G
JAMA Netw Open; 2021 Dec; 4(12):e2136823. PubMed ID: 34854905
[TBL] [Abstract][Full Text] [Related]
36. ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?
Bello DM; Ariyan CE
Ann Surg Oncol; 2020 Apr; 27(4):1189-1190. PubMed ID: 31953700
[No Abstract] [Full Text] [Related]
37. Immunotherapy Outcomes in Advanced Melanoma in Relation to Age.
Joshi K; Atwal D; Ravilla R; Pandey Y; Yarlagadda N; Kakadia S; Makhoul I; Hutchins L; Mahmoud F
Perm J; 2020; 24():. PubMed ID: 32097116
[TBL] [Abstract][Full Text] [Related]
38. The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach.
Xia X; Fan X; Zhao M; Zhu P
Curr Gene Ther; 2019; 19(2):117-124. PubMed ID: 31264548
[TBL] [Abstract][Full Text] [Related]
39. Targeting Ferroptosis to Iron Out Cancer.
Hassannia B; Vandenabeele P; Vanden Berghe T
Cancer Cell; 2019 Jun; 35(6):830-849. PubMed ID: 31105042
[TBL] [Abstract][Full Text] [Related]
40. miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.
Zhang K; Wu L; Zhang P; Luo M; Du J; Gao T; O'Connell D; Wang G; Wang H; Yang Y
Mol Carcinog; 2018 Nov; 57(11):1566-1576. PubMed ID: 30035324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
